News IQ-AI Limited

Equities

Delayed London Stock Exchange Other stock markets 10:10:34 2023-10-03 am EDT			5-day change	1st Jan Change
4.063 ^GBX	-12.63%		-28.73%	+122.60%

Sep. 19	IQ-AI Halts Trading on OTCQB Venture Market in US; London Shares Up 13%	MT
Sep. 08	IQ-AI Unit's Study Validates IB Neuro Platform for Reduced Gadolinium Approach on 1.5T MR Scanners	MT

IQ-AI Halts Trading on OTCQB Venture Market in US; London Shares Up 13%	Sep. 19	MT
IQ-AI Unit's Study Validates IB Neuro Platform for Reduced Gadolinium Approach on 1.5T MR Scanners	Sep. 08	MT
IQ-AI notes vindication of subsidiary's reduced gadolinium approach	Sep. 08	AN
Mayo Clinic Reverts IQ-AI Shares as IB Trax Deal Closes	Aug. 18	MT
IQ-AI Shares Up 18% as Unit Strikes Commercial Deal with GE HealthCare	Aug. 18	MT
IQ-AI shares jump on subsidiary's GE Healthcare deal	Aug. 18	AN
IQ-AI Ltd Announces Update on Collaboration Agreement with Mayo Clinic	Aug. 18	CI
IQ-AI interim loss narrows amid higher revenue, lower expenses	Aug. 17	AN
Earnings Flash (IQAI.L) IQ-AI Reports H1 Revenue GBP282,652	Aug. 17	MT
Earnings Flash (IQAI.L) IQ-AI Reports H1 Loss GBX-0.16	Aug. 17	MT
IQ-AI Limited Reports Earnings Results for the Half Year Ended June 30, 2023	Aug. 17	CI
IQ-AI Limited shares latest progress from Phase I glioblastoma clinical trial	Jul. 19	AQ
IQ-AI subsidiary's app adopted by US medical college	Jul. 19	AN
IQ-AI granted orphan drug designation for Gallium Galtolate	Jul. 13	AN
US FDA Approves Imaging Biometrics' Brain Tumor Drug for Pediatric Use	Jul. 13	MT
IQ-AI Shares Rise on FDA Orphan Designation for Pediatric Brain-Cancer Treatment	Jul. 13	DJ
IQ-AI notes Gallium Moltate studies on tumour growth	Jun. 27	AN
Harworth optimistic on 2027; Plexus extends agreement	May. 23	AN
Third Point Investors NAV per share drops by quarter	Apr. 26	AN
IQ-AI Limited Reports Earnings Results for the Full Year Ended December 31, 2022	Apr. 26	CI

No results for this search